|Articles|June 30, 2005

Smoking May Increase the Risk of Tuberculosis Infection

Smoking may increase the risk of developing tuberculosis infection, show researchers in the journal Thorax.

 

The study involved 2,401 adults from two urban communities in Cape Town, South Africa. Participants were surveyed about their smoking habits and underwent a tuberculin skin test. Factors such as age, sex, education level, body mass index, and income were taken into account.

 

Smoking was defined as having ever smoked for at least one year. The average number of cigarettes smoked per day was recorded for all ex-smokers and current smokers, and the number of pack-years smoked was calculated.

 

Of 1,309 current smokers or ex-smokers, 1,070 (82 percent) had a positive skin test. This was significantly higher than for never smokers. A positive relation with pack-years was also observed, with those smoking more than 15 pack-years having the highest risk.

 

The reason for the increased risk of infection in smokers is unclear, but may be explained by the effects of smoking on the ability of the lungs to fight off infection, say the authors.

 

They conclude that smoking may increase the risk of tuberculosis infection, and propose that further studies be conducted to investigate this association and to establish whether smoking reduction strategies contribute to tuberculosis control.

 

An accompanying editorial discusses whether this is a chance or causal association. The evidence from the literature does not support an effect of smoking on tuberculin responses, but perhaps the likelihood of developing active tuberculosis is greater in those who have smoked for a long time, says Dr. Graham Bothamley. Social factors are significant confounding factors in such studies.

 

 


Related to this article

Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.